A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with "bone-only" metastatic breast cancer

• Автори: Ilona Tornyi (Автор), Peter Árkosy (Автор), Ildikó Horváth (Автор), Andrea Furka (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

The vast majority of hormone positive and HER2 negative advanced breast cancers can be controlled well by endocrine therapy combined with the groundbreaking use of CDK4/6 inhibitors in the metastatic first-line setting. Approximately 50%-60% of these patients have "bone-only" metastatic di...